In this mental health market update episode, we are covering valuation trends, investor sentiment, and our 9 key takeaways from the mental health startup market heading into 2021. We cover public and private market valuation trends impacting mental...
In this episode, we chat with , CEO of Cybin. Cybin, is a life sciences company advancing mushroom based psychedelic pharmaceuticals and non-psychedelic nutraceutical products as potential therapies for psychiatric and neurological conditions.......Listen now
In this episode we speak with Dr. Errol De Souza, PhD, Executive Chairman of the Board of Directors at Bionomics. Bionomics just raised nearly $16mm to conduct clinical trials on their revolutionary drug to treat PTSD. Dr. De Souza is one......Listen now
In this episode we chat with long time healthcare startup investor, . Esther has been very influential in the healthcare investing space for quite some time. It’s very hard to run into anyone doing anything meaningful in the broader......Listen now